Discovery of <i>trans</i>-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4<i>S</i>)-methoxy-(2<i>S</i>)-pyrrolidinylmethoxy]cyclohexanecarboxylic Acid: An Orally Active, Selective Very Late Antigen-4 AntagonistFumihito Muro, Nobuo Machinaga, Masaki Setoguchi et al.|Journal of Medicinal Chemistry|2009Cited by 25
Development of a cell-free binding assay for rat ICAM-1/LFA-1 interactions using a novel anti-rat LFA-1 monoclonal antibody and comparison with a cell-based assayRyuta Mukasa, Tohru Takashi, Atsushi Satoh et al.|Journal of Immunological Methods|1999Cited by 8
Improvement of Pulmonary Function by Oral Treatment with a VLA-4 Antagonist in a Mouse Asthmatic ModelGensuke Takayama, Tohru Takashi, Yutaka Iigo et al.|Journal of Pharmacological Sciences|2013Cited by 3